S.N. Nuclearelectrica (BVB:SNN) Stock Sees Fair Value Cut As Analysts Turn More Cautious
BTIG Initiates Coverage On Smith & Nephew with Neutral Rating
Smith & Nephew (NYSE:SNN) Looks Undervalued on Decent Value Screen
Disappointing Ortho Performance Continues To Hold Smith & Nephew Back (Downgrade)
Smith & Nephew SNATS Q2 Earnings Call Highlights
Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript
Smith & Nephew plc 2026 Q2 - Results - Earnings Call Presentation
CORRECTION: Smith & Nephew Lowers FY2026 Sales Guidance from $6.534B to $6.411B vs $6.565B Est
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
Smith+Nephew's ESSA Spatial Surgery System Receives FDA's De Novo Classification
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis
Smith & Nephew: Ongoing Business Progress And A More Attractive Price
Canaccord Genuity Maintains Hold on Smith & Nephew, Lowers Price Target to $30
Smith & Nephew Sees FY2026 Sales $6.534B vs $6.557B Est
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
Smith & Nephew plc (SNN) Q1 2026 Sales/ Trading Statement Call - Slideshow
Smith+Nephew To Showcase ALLEVYNCOMPLETE CARE Dressing And RENASYS EDGE tNPWT, To Simplify Wound Management And Ease Clinical Burden At EWMA 2026
Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.